@article{e4b6c7854dc84ea18844188389cdbd91,
title = "A phase I trial of BKM120 (Buparlisib) in combination with fulvestrant in postmenopausal women with estrogen receptor-positive metastatic breast cancer",
keywords = "Phosphoinositide-3 Kinase Inhibitors, Aminopyridines/administration \& dosage, Humans, Middle Aged, Morpholines/administration \& dosage, Treatment Outcome, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Biomarkers, Tumor, Fulvestrant, Receptors, Estrogen/metabolism, Estradiol/administration \& dosage, Neoplasm Metastasis, PTEN Phosphohydrolase, Receptors, Progesterone, Postmenopause, Adult, Female, Aged, Breast Neoplasms/drug therapy",
author = "Ma, \{Cynthia X.\} and Jingqin Luo and Michael Naughton and Foluso Ademuyiwa and Rama Suresh and Malachi Griffith and Griffith, \{Obi L.\} and Skidmore, \{Zachary L.\} and Spies, \{Nicholas C.\} and Avinash Ramu and Lee Trani and Timothy Pluard and Gayathri Nagaraj and Shana Thomas and Zhanfang Guo and Jeremy Hoog and Jing Han and Elaine Mardis and Craig Lockhart and Ellis, \{Matthew J.\}",
note = "{\textcopyright}2015 American Association for Cancer Research.",
year = "2016",
month = apr,
day = "1",
doi = "10.1158/1078-0432.CCR-15-1745",
language = "English",
volume = "22",
pages = "1583--1591",
journal = "Clinical Cancer Research",
issn = "1078-0432",
number = "7",
}